Skip to main content

Table 4 ESC/ERS risk score 2015 assessments included

From: Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up

ESC/ERS risk score groups

Whole cohort

PAH

PAH with comorbidities

Baseline values

Kaplan-Meier

p-value

n

Kaplan-Meier

p-value

n

Kaplan-Meier

p-value

n

Survival

 6MWD

0.010

113

0.019

68

0.636

45

 NT-proBNP

0.031

104

0.032

64

0.260

40

 WHO functional class

0.004

126

0.016

77

0.491

49

 Right atrial area

0.045

135

0.013

84

0.774

51

Time to first clinical worsening event

 6MWD

0.011

112

0.031

67

0.129

45

 NT-proBNP

0.012

103

0.002

63

0.194

40

 WHO functional class

0.006

125

0.079

76

0.547

49

 Right atrial area

0.001

134

0.034

83

0.244

51

  1. 6MWD 6-min walking distance, NT-proBNP N-terminal pro brain natriuretic peptide, WHO World Health Organization